This series of meetings of experts, organized under the auspices of the Standing Committee on Advances and National Security Implications of Transdisciplinary Biotechnology, will bring together ...

J&K Ingredients has entered a partnership with Pallas Biotech Co. Ltd., a global biotechnology company, that brings together complementary capabilities across research and development, fermentation, ...

PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and ...

REHOVOT, Israel, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and ...

CRANBURY, N.J.--(BUSINESS WIRE)--Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery, today announced that the U.S. Food and Drug ...

WENZHOU, China, Jan. 6, 2026 /PRNewswire/ -- Recently, VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, ...

Cyanophycin is a versatile nitrogen storage polymer naturally synthesised by many bacteria. Composed of a poly-L-aspartate backbone with covalently attached L-arginine residues, this biopolymer ...

EQS-Ad-hoc: BRAIN Biotech AG / Key word(s): Strategic Company Decision BRAIN Biotech AG: prioritizing development of therapeutic applications of the Akribion Genomics technology platform ...

L-Glutaminase is an enzyme of marked significance in biotechnology, with applications ranging from therapeutic interventions in cancer treatment to the enhancement of umami flavour in fermented foods.

CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that the U.S. Food and ...

Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date. This series of meetings of experts, organized under the auspices of ...